Dr. Peter Gilbert is a biostatistician engaged in the design and analysis of clinical trials of candidate vaccines for HIV and other infectious diseases. His team specializes in data analyses of these trials to understand how vaccine efficacy depends on immune responses to vaccination and on genetic features of infectious pathogens — a field ...

See Fred Hutchinson's Dr. Peter Gilbert's appointments, affiliations, education, honors, and research interests.

Feb 7, 2025 · Peter Gilbert, Ph.D. Principal Investigator, HVTN Statistical and Data Management Center (SDMC) Dr. Gilbert is professor of Biostatistics, Bioinformatics, and Epidemiology within the Vaccine and Infectious Disease Division and professor of …

Dr. Peter Gilbert is a biostatistician with many years of experience in the design and analysis of randomized clinical trials for preventive vaccines against HIV, malaria, dengue, and other pathogens; as well as for MTCT prevention and antiretroviral therapies.

Peter Gilbert (born 1957 or 1958 [1]) is an American documentary filmmaker, film producer, and cinematographer. He was the cinematographer and one of the producers of Hoop Dreams, a 1994 documentary about two teenage basketball players in Chicago. [2]

Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing … M Li, F Gao, JR Mascola, L Stamatatos, VR...

The Gilbert Group at Fred Hutchinson Cancer Research Center researches the statistical design and analysis of vaccine efficacy trials, especially HIV Vaccine Trials Network (HVTN) trials of candidate HIV vaccines.

Peter Gilbert may refer to: Peter Gilbert (Welsh footballer) (born 1983), Welsh footballer and coach; Pete Gilbert (artist) (born 1948), British artist; Pete Gilbert (baseball) (1867–1912), baseball player; Peter Gilbert (Australian footballer) (born 1948), former Australian rules footballer

Closely connected to its HVTN research on HIV vaccines, the Gilbert Group also focuses on HVTN efficacy trials of broadly neutralizing monoclonal antibodies for prevention of HIV acquisition, and on COVID-19 Prevention Network (CoVPN) …

Nov 28, 2023 · In the early 1990s, Peter Gilbert was a University of Washington (UW) undergraduate, wondering what to do with his math degree. At this time, the HIV/AIDS epidemic was reaching its peak in mortality rates, and treatment for HIV (antiretroviral therapies) had not yet been developed.